Folia Microbiologica

, Volume 64, Issue 6, pp 861–865 | Cite as

Antibiotic susceptibility and production of endotoxin by Ochrobactrum anthropi isolated from environment and from patients with cystic fibrosis

  • Dittmar Chmelař
  • Ondřej HolýEmail author
  • Iveta Kasáková
  • Michal Hájek
  • Anna Lazarová
  • Carlos Gonzalez-Rey
  • Jakub Lasák
  • Vladislav Raclavský
  • Ivan Čižnár
Short Communication


The aim of this work was to compare production of endotoxin and to determine susceptibility to antibiotics in two groups of specimens—wild-type strains Ochrobactrum anthropi isolated from the environment and the strains isolated from patients with cystic fibrosis. The determination of the endotoxin produced by the test strains was carried on by using a limulus amebocyte lysate test (LAL test). Determination of ATB sensitivity was accomplished by means of a broth dilution method in a microtiter plate (MIC). No significant difference was found between the group of ochrobacters isolated from the environment and the group of ochrobacters isolated from cystic fibrosis patients. Antibiotic sensitivity testing has indicated that the resistance to tigecycline, trimethoprim/sulfamethoxazole, and gentamicin was slightly higher in strains isolated from cystic fibrosis patients in comparison with strains isolated from the environment. In general, most of the test strains were sensitive to most of the antibiotics tested. Significant resistance has been demonstrated for cefotaxime. Resistance was also found for gentamicin in strains number 4 and 7. The MIC was equal to the breakpoint for this antibiotic (8000 mg/L).



The research did not receive specific funding, but was performed as part of the employment of the authors of the Faculty of Medicine, University of Ostrava, Czech Republic; Department of Public Health, Faculty of Medicine and Dentistry, Palacký University Olomouc, Czech Republic; Centre of Hyperbaric Medicine, Ostrava City Hospital, Czech Republic; Department of Neonatology, University Hospital Olomouc, Czech Republic; Swedish Orphan Biovitrum AB, Stockholm, Sweden; and Department of Microbiology, Faculty of Medicine and Dentistry, Palacký University Olomouc, Czech Republic.

Authors’ contributions

DCh: the author of the article and scenario of experiments and article writing; OH: the corresponding author, suggestions and checking the manuscript; IK, AL, MH: organization of experimental work in the Faculty of Medicine of University of Ostrava; CG-R, JL, VR, IČ: suggestions and checking the manuscript.

Compliance with ethical standards

Additional informed consent was obtained from all individual patients included in the study article.

Conflict of interest

The authors declare that they have no conflict of interest.


  1. Chmelař D, Vrtný J (2010) Endotoxin production in members of the Bacteroides fragilis group in relation to colorectal cancer humans. Klin Mikrobiol Infec Lek 16(3):97–102Google Scholar
  2. Chmelař D, Hájek M, Janečková J, Vobejdová J, Martineková P, Kašíková A (2016) The effect of oxygen on endotoxin production in bacteria of the Bacteroides fragilis group isolated from patients with colorectal carcinoma. Epidemiol Mikrobiol Imunol 2:129–135Google Scholar
  3. Chmelař D, Kašíková A, Martineková P, Hájek M, Janečková J, Rozložník M, Brabec J, Janečková J et al (2018) Effect of hyperbaric air on endotoxin from Bacteroides fragilis strains. Folia Microbiol 63(3):283–290. CrossRefGoogle Scholar
  4. Cutting GR (2015) Cystic fibrosis genetics: from molecular understanding to clinical application. Nat Rev Genet 16(1):45–56CrossRefGoogle Scholar
  5. Davies JC, Alton EWFW, Bush A (2007) Cystic fibrosis. B M J 335:1255–1259CrossRefGoogle Scholar
  6. EUCAST (2019) Breakpoint tables for interpretation of MICs and zone diameters. Version 9.0, valid from 2019-01-01. [on line]
  7. Hagiya H, Ohnishi K, Maki M, Watanabe N, Murase T (2013) Clinical characteristics of Ochrobactrum anthropi bacteremia. J Clin Microbiol 51(4):1330–1333CrossRefGoogle Scholar
  8. Higgins CS, Avison MB, Jamieson L et al (2001) Characterization, cloning and sequence analysis of the inducible Ochrobactrum anthropi AmpC beta-lactamase. J Antimicrob Chemother 47(6):745–754CrossRefGoogle Scholar
  9. Holmes B, Popoff M, Kiredjian M et al (1988) Ochrobactrum anthropi gen. nov., sp. nov. from human clinical specimens and previously known as group Vd. Int J Syst Evol Microbiol 38:406–416Google Scholar
  10. Holý O, Matoušková I, Raida L (2012) The incidence of gram-negative bacteria in the environment of the Transplant Unit, Department of Hemato-oncology, University Hospital—Olomouc. Epidemiol Mikrobiol Imunol 61(4):103–109PubMedGoogle Scholar
  11. Kettaneh A, Weill F-X, Poilane I, Fain O, Thomas M, Herrmann JL, Hocqueloux L (2003) Septic shock caused by Ochrobactrum anthropi in an otherwise healthy host. J Clin Microbiol 41(3):1339–1341CrossRefGoogle Scholar
  12. Kreda SM, Davis CW, Rose MC (2012) CFTR, mucins, and mucus obstruction in cystic fibrosis. Cold Spring Harb Perspect Med 2(9):a00958CrossRefGoogle Scholar
  13. Lebuhn M, Achouak W, Schloter M, Berge O, Meier H, Barakat M, Hartmann A, Heulin T (2000) Taxonomic characterization of Ochrobactrum spp. isolates from soil samples and wheat roots, and description of Ochrobactrum tritici sp. nov. and Ochrobactrum grignonense sp. nov. Int J Syst Evol Microbiol 50(6):2207–2223CrossRefGoogle Scholar
  14. Liu D (2011) Molecular detection of human bacterial pathogens. CRC Press, Boca RatonCrossRefGoogle Scholar
  15. Macek M Jr, Macek M Sr, Krebsová A et al (1997) Possible association of the allele status of the CS.7/Hha I polymorphism 5′ of the CFTR gene with postnatal female survival. Hum Genet 99(5):565–572CrossRefGoogle Scholar
  16. Matoušková I, Holý O (2013) Bacterial contamination of the internal air of the transplant unit. Epidemiol Mikrobiol Imunol 62(4):153–159PubMedGoogle Scholar
  17. Matoušková I, Holý O (2014) Monitoring of the environment at the transplant unit—hemato-oncology clinic. Int J Environ Res Public Health 11(9):9480–9490CrossRefGoogle Scholar
  18. Matoušková I, Raida L, Holý O (2012) The incidence of nonfermentative gram-negative bacilli in the environment of the Transplant Unit, Department of Hemato-oncology, University Hospital Olomouc. Epidemiol Mikrobiol Imunol 61(4):110–115PubMedGoogle Scholar
  19. Namavar F, Theunissen EB, Verweij-Van Vught AMJJ (1989) Epidemiology of the Bacteroides fragilis group in the colonic flora of patients with colonic cancer. J Med Microbiol 29:171–176CrossRefGoogle Scholar
  20. Rosenstein BJ, Cutting GR (1998) The diagnosis of cystic fibrosis: a consensus statement. Cystic Fibrosis Foundation Consensus Panel. J Ped 132(4):589–595CrossRefGoogle Scholar
  21. Thoma B, Straube E, Scholz HC, al Dahouk S, Zöller L, Pfeffer M, Neubauer H, Tomaso H (2009) Identification and antimicrobial susceptibilities of Ochrobactrum spp. Int J Med Microbiol 299(3):209–220CrossRefGoogle Scholar
  22. Velasco J, Romero C, Lopez-Goni I et al (1998) Evaluation of the relatedness of Brucella spp. and Ochrobactrum anthropi and description of Ochrobactrum intermedium sp. nov., a new species with a closer relationship to Brucella spp. Int J Syst Evol Microbiol 48:759–768Google Scholar
  23. Welsh MJ (1999) Gene transfer for cystic fibrosis. J Clin Invest 104(9):1165–1166CrossRefGoogle Scholar
  24. Welsh MJ, Ramsey BW, Accurso F et al (2001) The cystic fibrosis. In: Scriver CR, Beaudet AL, Sly WS et al (eds) The metabolic and molecular basis of inherited diseases. McGraw-Hill, New York, pp 5121–5188Google Scholar

Copyright information

© Institute of Microbiology, Academy of Sciences of the Czech Republic, v.v.i. 2019

Authors and Affiliations

  • Dittmar Chmelař
    • 1
  • Ondřej Holý
    • 2
    Email author
  • Iveta Kasáková
    • 1
  • Michal Hájek
    • 1
    • 3
  • Anna Lazarová
    • 1
    • 4
  • Carlos Gonzalez-Rey
    • 5
  • Jakub Lasák
    • 6
  • Vladislav Raclavský
    • 7
  • Ivan Čižnár
    • 1
    • 8
  1. 1.Department of Biomedical Sciences, Institute of Microbiology and Immunology, Faculty of MedicineUniversity of OstravaOstravaCzech Republic
  2. 2.Department of Public Health, Faculty of Medicine and DentistryPalacký University OlomoucOlomoucCzech Republic
  3. 3.Centre of Hyperbaric MedicineOstrava City HospitalOstravaCzech Republic
  4. 4.Department of Immunology and AlergologyPublic Health Institute OstravaOstravaCzech Republic
  5. 5.Swedish Orphan Biovitrum ABStockholmSweden
  6. 6.Department of NeonatologyUniversity Hospital OlomoucOlomoucCzech Republic
  7. 7.Department of Microbiology, Faculty of Medicine and DentistryPalacký University OlomoucOlomoucCzech Republic
  8. 8.Faculty of Public HealthSlovak Medical University in BratislavaBratislavaSlovak Republic

Personalised recommendations